BIOVENTUS CLASS A INC (BVS) — insider trading
Health Care · NASDAQ
BIOVENTUS CLASS A INC (BVS) has 32 reported SEC Form 4 insider transactions in our data (latest 2026-06-03).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Beyer Pat | Director | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Cowdy Philip G. | Director | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-03 | HAWKINS WILLIAM A | Director | Grant / award / vesting (derivative) | 30,994 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Ladone Mary Kay | Director | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-03 | McMurry-Heath Michelle | Director | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-03 | NEELS GUIDO J | Director | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-03 | NOHRA GUY P | Director | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-03 | STALNECKER SUSAN M | Director | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-03 | SUTTER MARTIN P | Director, 10% owner | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Bartholdson John A. | Director, 10% owner | Grant / award / vesting (derivative) | 25,146 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Beyer Pat | Director | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Beyer Pat | Director | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Cowdy Philip G. | Director | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Cowdy Philip G. | Director | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | HAWKINS WILLIAM A | Director | Option exercise / conversion (derivative) | 39,789 | $0.00 | $0 | Form 4 |
| 2026-06-02 | HAWKINS WILLIAM A | Director | Option exercise / conversion | 39,789 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Ladone Mary Kay | Director | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Ladone Mary Kay | Director | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | McMurry-Heath Michelle | Director | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | McMurry-Heath Michelle | Director | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | NEELS GUIDO J | Director | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | NEELS GUIDO J | Director | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | NOHRA GUY P | Director | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | NOHRA GUY P | Director | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | STALNECKER SUSAN M | Director | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | STALNECKER SUSAN M | Director | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | SUTTER MARTIN P | Director, 10% owner | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | SUTTER MARTIN P | Director, 10% owner | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Bartholdson John A. | Director, 10% owner | Option exercise / conversion (derivative) | 32,282 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Bartholdson John A. | Director, 10% owner | Option exercise / conversion | 32,282 | $0.00 | $0 | Form 4 |
| 2021-04-01 | Cowdy Philip G. | Director | Grant / award / vesting (derivative) | 2,700 | $0.00 | $0 | Form 4/A |
| 2021-02-11 | Cowdy Philip G. | Director | Grant / award / vesting (derivative) | 9,000 | $0.00 | $0 | Form 4/A |
Ask the chat about BVS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: BIOVENTUS CLASS A INC (BVS).
Last updated 2026-06-03 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.